Armed with $6.3 million in new pre-seed capital, Synonym Biotechnologies has begun the development phase for its first productized bio-manufacturing facilities for non-pharmaceutical applications.
Edward Shenderovich and Joshua Lachter started the company in January 2022 to develop, finance and build commercial-scale bio-manufacturing facilities to provide synthetic biology producers of all size with flexible production capacity while also giving infrastructure investors access to a new, carbon-negative bio-manufacturing asset class they are calling “fermentation farms.”
Andreessen Horowitz, Giant Ventures, Blue Horizon, Thia Ventures and other venture funds active in decarbonization were part of the investment.
Shenderovich and Lachter closed on the funding
